🟢 Liquidia Technologies is trading 10% up today as biotech and broader markets rally

Liquidia Technologies is trading at $46.83, up 10.12%, in line with biotech and broader-market strength; no clear company-specific announcement explains the November 4 move.

• Biotech ETF XBI is up 2.13%, while major market indices are also sharply higher.
• Liquidia’s Q3 results are scheduled for November 10.
• Available evidence points to sector and broader-market sentiment rather than a new Liquidia catalyst.